Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial (Q35019136)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trial (English)

1 reference

Europe PubMed Central

5 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

John Lally

5

0 references

object named as

Fiona Gaughran

1

0 references

Kathryn Greenwood

object named as

Kathryn E Greenwood

15

0 references

object named as

Anita Patel

7

0 references

object named as

Khalida Ismail

3

0 references

object named as

Daniel Stahl

2

0 references

object named as

Robin M Murray

14

0 references

4

object named as

Zerrin Atakan

1 reference

Europe PubMed Central

5 August 2017

8

object named as

Anthony David

1 reference

Europe PubMed Central

5 August 2017

Poonam Gardner Sood

6

object named as

Poonam Gardner-Sood

1 reference

Europe PubMed Central

5 August 2017

11

object named as

Philippa Lowe

1 reference

Europe PubMed Central

5 August 2017

Maurice Arbuthnot

13

object named as

Maurice Arbuthnot

1 reference

Europe PubMed Central

5 August 2017

Shubulade Smith

16

object named as

Shubulade Smith

1 reference

Europe PubMed Central

5 August 2017

author name string

David Hopkins

9

1 reference

Europe PubMed Central

5 August 2017

Bee Harries

10

1 reference

Europe PubMed Central

5 August 2017

Diana Orr

12

1 reference

Europe PubMed Central

5 August 2017

publication date

16 October 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

13

1 reference

Europe PubMed Central

5 August 2017

263

1 reference

Europe PubMed Central

5 August 2017

https://scigraph.springernature.com/pub.10.1186/1471-244x-13-263

0 references

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Strategy for intention to treat analysis in randomised trials with missing outcome data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Current Directions in Mediation Analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Twenty-five year mortality of a community cohort with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Premature mortality from general medical illnesses among persons with bipolar disorder: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

The metabolic syndrome and schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Effects of cannabis use on outcomes of psychotic disorders: systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

A Systematic Review of Mortality in Schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Schizophrenia and increased risks of cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Modified tobacco use and lifestyle change in risk-reducing beliefs about smoking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

CONSORT statement: extension to cluster randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

International physical activity questionnaire: 12-country reliability and validity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

The estimation of a preference-based measure of health from the SF-36.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Causes of the excess mortality of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Compliance therapy in psychotic patients: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Dietary intervention in primary care: validity of the DINE method for diet assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Schizophrenia and smoking: an epidemiological survey in a state hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

8 July 2018

Mental disorders and cause-specific mortality.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Developments in cluster randomized trials and Statistics in Medicine.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Design and analysis of clinical trials with clustering effects due to treatment.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

25 October 2018

Client Socio-Demographic and Service Receipt Inventory--European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3852764

25 October 2018

Cannabis use and outcome of recent onset psychosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-263

21 January 2018

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24131496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24131496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality of patients with mood disorders: follow-up over 34-38 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/24131496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Life expectancy among persons with schizophrenia or bipolar affective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24131496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An investigation of models of illness in carers of schizophrenia patients using the Illness Perception Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/24131496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24131496

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-13-263

1 reference

Europe PubMed Central

5 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35019136&oldid=2117519222"